Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Wahren, B
   HIV in Europe - a growing threat
   JOURNAL OF CLINICAL VIROLOGY
   
   B. Wahren, "HIV in Europe - a growing threat", J CLIN VIRO, 21(2), 2001, pp. 171-173
2. Calarota, SA; Kjerrstrom, A; Islam, KB; Wahren, B
   Gene combination raises broad human immunodeficiency virus-specific cytotoxicity
   HUMAN GENE THERAPY
   
   S.A. Calarota et al., "Gene combination raises broad human immunodeficiency virus-specific cytotoxicity", HUM GENE TH, 12(13), 2001, pp. 1623-1637
3. Zuber, B; Bottiger, D; Benthin, R; Ten Haaft, P; Heeney, J; Wahren, B; Oberg, B
   An in vivo model for HIV resistance development
   AIDS RESEARCH AND HUMAN RETROVIRUSES
   
   B. Zuber et al., "An in vivo model for HIV resistance development", AIDS RES H, 17(7), 2001, pp. 631-635
4. Hejdeman, B; Lenkei, R; Leandersson, AC; Hultstrom, AL; Wahren, B; Sandstrom, E; Bratt, G
   Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection
   AIDS RESEARCH AND HUMAN RETROVIRUSES
   
   B. Hejdeman et al., "Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection", AIDS RES H, 17(4), 2001, pp. 277-286
5. Tadokoro, K; Koizumi, Y; Miyagi, Y; Kojima, Y; Kawamoto, S; Hamajima, K; Okuda, K; Tanaka, S; Onari, K; Wahren, B; Aoki, I; Okuda, K
   Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration
   VIRAL IMMUNOLOGY
   
   K. Tadokoro et al., "Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration", VIRAL IMMUN, 14(2), 2001, pp. 159-167
6. Bolmstedt, A; Hinkula, J; Rowcliffe, E; Biller, M; Wahren, B; Olofsson, S
   Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan
   VACCINE
   
   A. Bolmstedt et al., "Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan", VACCINE, 20(3-4), 2001, pp. 397-405
7. Watabe, S; Xin, KQ; Ihata, A; Liu, LJ; Honsho, A; Aoki, I; Hamajima, K; Wahren, B; Okuda, K
   Protection against influenza virus challenge by topical application of influenza DNA vaccine
   VACCINE
   
   S. Watabe et al., "Protection against influenza virus challenge by topical application of influenza DNA vaccine", VACCINE, 19(31), 2001, pp. 4434-4444
8. Tahtinen, M; Strengell, M; Collings, A; Pitkanen, J; Kjerrstrom, A; Hakkarainen, K; Peterson, P; Kohleisen, B; Wahren, B; Ranki, A; Ustav, M; Krohn, K
   DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector
   VACCINE
   
   M. Tahtinen et al., "DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector", VACCINE, 19(15-16), 2001, pp. 2039-2047
9. Kjerrstrom, A; Hinkula, J; Engstrom, G; Ovod, V; Krohn, K; Benthin, R; Wahren, B
   Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines
   VIROLOGY
   
   A. Kjerrstrom et al., "Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines", VIROLOGY, 284(1), 2001, pp. 46-61
10. Calarota, SA; Wahren, B
    Cellular HIV-1 immune responses in natural infection and after genetic immunization
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    
    S.A. Calarota e B. Wahren, "Cellular HIV-1 immune responses in natural infection and after genetic immunization", SC J IN DIS, 33(2), 2001, pp. 83-96
11. Xu, LY; Ishikawa, M; Huang, YM; Levi, M; van der Meide, PH; Wahren, B; Link, H; Xiao, BG
    The complexity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats
    CLINICAL IMMUNOLOGY
    
    L.Y. Xu et al., "The complexity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats", CLIN IMMUNO, 95(1), 2000, pp. 70-78
12. Skjoldebrand-Sparre, K; Tolfvenstam, T; Papadogiannakis, N; Wahren, B; Broliden, K; Nyman, M
    Parvovirus B19 infection: association with third-trimester intrauterine fetal death
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    K. Skjoldebrand-Sparre et al., "Parvovirus B19 infection: association with third-trimester intrauterine fetal death", BR J OBST G, 107(4), 2000, pp. 476-480
13. Broliden, K; Petterson, K; Papadogiannakis, N; Wahren, B; Skjoldebrand-Sparre, L; Nyman, M
    Parvovirus B19 infection: association with third-trimester intrauterine fetal death - Authors' reply
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    K. Broliden et al., "Parvovirus B19 infection: association with third-trimester intrauterine fetal death - Authors' reply", BR J OBST G, 107(10), 2000, pp. 1324-1324
14. Tolfvenstam, T; Enbom, M; Ghebrekidan, H; Ruden, U; Linde, A; Grandien, M; Wahren, B
    Seroprevalence of viral childhood infections in Eritrea
    JOURNAL OF CLINICAL VIROLOGY
    
    T. Tolfvenstam et al., "Seroprevalence of viral childhood infections in Eritrea", J CLIN VIRO, 16(1), 2000, pp. 49-54
15. Isaguliants, MG; Gudima, SO; Ivanova, OV; Levi, M; Hinkula, J; Garaev, MM; Kochetkov, SN; Wahren, B
    Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    M.G. Isaguliants et al., "Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits", AIDS RES H, 16(13), 2000, pp. 1269-1280
16. Levi, M; Hinkula, J; Wahren, B
    A retro-inverso miniantibody with anti-HIV activity
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    M. Levi et al., "A retro-inverso miniantibody with anti-HIV activity", AIDS RES H, 16(1), 2000, pp. 59-65
17. Zou, LP; Ljunggren, HG; Levi, M; Nennesmo, I; Wahren, B; Mix, E; Winblad, B; Schalling, M; Zhu, J
    P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice
    JOURNAL OF NEUROSCIENCE RESEARCH
    
    L.P. Zou et al., "P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice", J NEUROSC R, 62(5), 2000, pp. 717-721
18. Isaguliants, MG; Petrakova, N; Zuber, B; Pokrovskaya, K; Gizatullin, R; Kostyuk, DA; Kjerrstrom, A; Winberg, G; Kochetkov, SN; Hinkula, J; Wahren, B
    DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not theinactive mutant, confers resistance to experimental HIV-1 challenge
    INTERVIROLOGY
    
    M.G. Isaguliants et al., "DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not theinactive mutant, confers resistance to experimental HIV-1 challenge", INTERVIROLO, 43(4-6), 2000, pp. 288-293
19. Hulstrom, AL; Hejdeman, B; Leandersson, AC; Bratt, G; Carbone, E; Wahren, B
    Human natural killer cells in asymptomatic human immunodeficiency virus-1 Infection
    INTERVIROLOGY
    
    A.L. Hulstrom et al., "Human natural killer cells in asymptomatic human immunodeficiency virus-1 Infection", INTERVIROLO, 43(4-6), 2000, pp. 294-301
20. Tolfvenstam, T; Lundqvist, A; Levi, M; Wahren, B; Broliden, K
    Mapping of B-cell epitopes on human Parvovirus B19 non-structural and structural proteins
    VACCINE
    
    T. Tolfvenstam et al., "Mapping of B-cell epitopes on human Parvovirus B19 non-structural and structural proteins", VACCINE, 19(7-8), 2000, pp. 758-763
21. Xu, LY; Yang, JS; Huang, YM; van der Meide, PH; Levi, M; Wahren, B; Link, H; Xiao, BG
    Limitation of nitric oxide production: cells from lymph node and spleen exhibit distinct difference in nitric oxide production
    IMMUNOLOGY LETTERS
    
    L.Y. Xu et al., "Limitation of nitric oxide production: cells from lymph node and spleen exhibit distinct difference in nitric oxide production", IMMUNOL LET, 71(3), 2000, pp. 177-184
22. Mousavi-Jazi, M; Sundqvist, VA; Linde, A; Wahren, B; Brytting, M
    Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity
    JOURNAL OF MEDICAL VIROLOGY
    
    M. Mousavi-Jazi et al., "Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity", J MED VIROL, 62(2), 2000, pp. 117-126
23. Zuber, B; Hinkula, J; Vodros, D; Lundholm, P; Nilsson, C; Morner, A; Levi, M; Benthin, R; Wahren, B
    Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge
    VIROLOGY
    
    B. Zuber et al., "Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge", VIROLOGY, 278(2), 2000, pp. 400-411
24. Sandberg, JK; Leandersson, AC; Devito, C; Kohleisen, B; Erfle, V; Achour, A; Levi, M; Schwartz, S; Karre, K; Wahren, B; Hinkula, J
    Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization
    VIROLOGY
    
    J.K. Sandberg et al., "Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization", VIROLOGY, 273(1), 2000, pp. 112-119
25. Ljungberg, K; Wahren, B; Almqvist, J; Hinkula, J; Linde, A; Winberg, G
    Effective construction of DNA vaccines against variable influenza genes byhomologous recombination
    VIROLOGY
    
    K. Ljungberg et al., "Effective construction of DNA vaccines against variable influenza genes byhomologous recombination", VIROLOGY, 268(2), 2000, pp. 244-250
26. Zou, LP; Deretzi, G; Levi, M; Wahren, B; Quiding, C; van der Meide, P; Zhu, J
    Rolipram suppresses experimental autoimmune neuritis and prevents relapsesin Lewis rats
    NEUROPHARMACOLOGY
    
    L.P. Zou et al., "Rolipram suppresses experimental autoimmune neuritis and prevents relapsesin Lewis rats", NEUROPHARM, 39(2), 2000, pp. 324-333
27. Leandersson, AC; Gilljam, G; Fredriksson, M; Hinkula, J; Alaeus, A; Lidman, K; Albert, J; Bratt, G; Sandstrom, E; Wahren, B
    Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1
    JOURNAL OF VIROLOGY
    
    A.C. Leandersson et al., "Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1", J VIROLOGY, 74(10), 2000, pp. 4888-4890
28. Cerboni, C; Mousavi-Jazi, M; Linde, A; Soderstrom, K; Brytting, M; Wahren, B; Karre, K; Carbone, E
    Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts
    JOURNAL OF IMMUNOLOGY
    
    C. Cerboni et al., "Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts", J IMMUNOL, 164(9), 2000, pp. 4775-4782
29. Asakura, Y; Liu, LJ; Shono, N; Hinkula, J; Kjerrstrom, A; Aoki, I; Okuda, K; Wahren, B; Fukushima, J
    Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    Y. Asakura et al., "Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production", CLIN EXP IM, 119(1), 2000, pp. 130-139
30. Andersson, S; Tessema, HG; Wahren, B
    Is there a focus of HTLV-II infections in the horn of Africa?
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    
    S. Andersson et al., "Is there a focus of HTLV-II infections in the horn of Africa?", J ACQ IMM D, 21(4), 1999, pp. 353-354
31. Asakura, Y; Lundholm, P; Kjerrstrom, A; Benthin, R; Lucht, E; Fukushima, J; Schwartz, S; Okuda, K; Wahren, B; Hinkula, J
    DNA-plasmids of HIV-1 induce systemic and mucosal immune responses
    BIOLOGICAL CHEMISTRY
    
    Y. Asakura et al., "DNA-plasmids of HIV-1 induce systemic and mucosal immune responses", BIOL CHEM, 380(3), 1999, pp. 375-379
32. Enbom, M; Tolfvenstam, T; Ghebrekidan, H; Ruden, U; Grandien, M; Wahren, B; Linde, A
    Seroprevalence of human herpes virus 8 in different Eritrean population groups
    JOURNAL OF CLINICAL VIROLOGY
    
    M. Enbom et al., "Seroprevalence of human herpes virus 8 in different Eritrean population groups", J CLIN VIRO, 14(3), 1999, pp. 167-172
33. Levi, M; Ruden, U; Carlberg, H; Wahren, B
    The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies
    JOURNAL OF CLINICAL VIROLOGY
    
    M. Levi et al., "The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies", J CLIN VIRO, 12(3), 1999, pp. 243-252
34. Ghebrekidan, H; Ruden, U; Cox, S; Wahren, B; Grandien, M
    Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea
    JOURNAL OF CLINICAL VIROLOGY
    
    H. Ghebrekidan et al., "Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea", J CLIN VIRO, 12(1), 1999, pp. 53-64
35. Bratt, G; Eriksson, LE; Sandstrom, E; Gilljam, G; Hinkula, J; Albert, J; Redfield, R; Wahren, B
    Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment
    INTERNATIONAL JOURNAL OF STD & AIDS
    
    G. Bratt et al., "Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment", INT J STD A, 10(8), 1999, pp. 514-521
36. Deretzi, G; Zou, LP; Pelidou, SH; Nennesmo, I; Levi, M; Wahren, B; Mix, E; Zhu, J
    Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination
    JOURNAL OF AUTOIMMUNITY
    
    G. Deretzi et al., "Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination", J AUTOIMMUN, 12(2), 1999, pp. 81-89
37. Gilljam, G; Svensson, A; Ekstrom, A; Wahren, B
    Immunological responses to envelope glycoprotein 120 from subtypes of human immunodeficiency virus type 1
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    G. Gilljam et al., "Immunological responses to envelope glycoprotein 120 from subtypes of human immunodeficiency virus type 1", AIDS RES H, 15(10), 1999, pp. 899-907
38. Wang, HB; Li, H; He, B; Bakheit, M; Levi, M; Wahren, B; Berglof, A; Sandstedt, K; Link, H; Shi, FD
    The role of B-cells in experimental myasthenia gravis in mice
    BIOMEDICINE & PHARMACOTHERAPY
    
    H.B. Wang et al., "The role of B-cells in experimental myasthenia gravis in mice", BIOMED PHAR, 53(5-6), 1999, pp. 227-233
39. Mosolits, S; Harmenberg, U; Ruden, U; Ohman, L; Nilsson, B; Wahren, B; Fagerberg, J; Mellstedt, H
    Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    S. Mosolits et al., "Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma", CANCER IMMU, 47(6), 1999, pp. 315-320
40. Wahren, B
    Immunogenetic properties of genes
    ACTA ONCOLOGICA
    
    B. Wahren, "Immunogenetic properties of genes", ACTA ONCOL, 38(3), 1999, pp. 309-311
41. Lundholm, P; Asakura, Y; Hinkula, J; Lucht, E; Wahren, B
    Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA
    VACCINE
    
    P. Lundholm et al., "Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA", VACCINE, 17(15-16), 1999, pp. 2036-2042
42. Kjerrstrom, A; Wahren, B
    Expression of HIV regulatory DNA vaccine constructs
    BIOGENIC AMINES
    
    A. Kjerrstrom e B. Wahren, "Expression of HIV regulatory DNA vaccine constructs", BIOG AMINE, 15(1), 1999, pp. 93-112
43. Hultcrantz, R; Olsson, R; Danielsson, B; Jarnerot, C; Loof, L; Ryden, BO; Wahren, B; Broome, U
    A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis
    JOURNAL OF HEPATOLOGY
    
    R. Hultcrantz et al., "A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis", J HEPATOL, 30(4), 1999, pp. 669-673
44. Heeney, JL; Beverley, P; McMichael, A; Shearer, G; Strominger, J; Wahren, B; Weber, J; Gotch, F
    Immune correlates of protection from HIV and AIDS - more answers but yet more questions
    IMMUNOLOGY TODAY
    
    J.L. Heeney et al., "Immune correlates of protection from HIV and AIDS - more answers but yet more questions", IMMUNOL TOD, 20(6), 1999, pp. 247-251
45. Zou, LP; Ma, DH; Levi, M; Wahren, B; Wei, L; Mix, E; van der Meide, PH; Link, H; Zhu, J
    Antigen-specific immunosuppression: nasal tolerance to P0 protein peptidesfor the prevention and treatment of experimental autoimmune neuritis in Lewis rats
    JOURNAL OF NEUROIMMUNOLOGY
    
    L.P. Zou et al., "Antigen-specific immunosuppression: nasal tolerance to P0 protein peptidesfor the prevention and treatment of experimental autoimmune neuritis in Lewis rats", J NEUROIMM, 94(1-2), 1999, pp. 109-121
46. Zhu, J; Nennesmo, I; Deng, GM; Levi, M; Wahren, B; Diab, A; Mix, E; Zhou, JN; Ljunggren, HG
    Induction of experimental autoimmune neuritis in CD4(-)8(-) C57BL/6J mice
    JOURNAL OF NEUROIMMUNOLOGY
    
    J. Zhu et al., "Induction of experimental autoimmune neuritis in CD4(-)8(-) C57BL/6J mice", J NEUROIMM, 94(1-2), 1999, pp. 196-203
47. Sandstom, EG; Wahren, B
    Immunisation with gp160 in HIV-1 infection - Reply
    LANCET
    
    E.G. Sandstom e B. Wahren, "Immunisation with gp160 in HIV-1 infection - Reply", LANCET, 354(9182), 1999, pp. 949-949
48. Sandstrom, E; Wahren, B
    Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial
    LANCET
    
    E. Sandstrom e B. Wahren, "Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial", LANCET, 353(9166), 1999, pp. 1735-1742
49. Andang, M; Hinkula, J; Hotchkiss, G; Larsson, S; Britton, S; Wong-Staal, F; Wahren, B; Ahrlund-Richter, L
    Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    M. Andang et al., "Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model", P NAS US, 96(22), 1999, pp. 12749-12753
50. Calarota, SA; Leandersson, AC; Bratt, G; Hinkula, J; Klinman, DM; Weinhold, KJ; Sandstrom, E; Wahren, B
    Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment
    JOURNAL OF IMMUNOLOGY
    
    S.A. Calarota et al., "Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment", J IMMUNOL, 163(4), 1999, pp. 2330-2338
51. Jackson, NAC; Levi, M; Wahren, B; Dimmock, NJ
    Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type1 virions
    JOURNAL OF GENERAL VIROLOGY
    
    N.A.C. Jackson et al., "Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type1 virions", J GEN VIROL, 80, 1999, pp. 225-236
52. Deretzi, G; Pelidou, SH; Zou, LP; Quiding, C; Mix, E; Levi, M; Wahren, B; Zhu, J
    Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6
    IMMUNOLOGY
    
    G. Deretzi et al., "Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6", IMMUNOLOGY, 97(1), 1999, pp. 69-76
53. Isaguliants, MG; Pokrovskaya, K; Kashuba, VI; Pokholok, D; Hinkula, J; Wahren, B; Kochetkov, SN
    Eukaryotic expression of enzymatically active human immunodeficiency virustype 1 reverse transcriptase
    FEBS LETTERS
    
    M.G. Isaguliants et al., "Eukaryotic expression of enzymatically active human immunodeficiency virustype 1 reverse transcriptase", FEBS LETTER, 447(2-3), 1999, pp. 232-236
54. Xu, LY; Huang, YM; Yang, JS; Van der Meide, PH; Levi, M; Wahren, B; Link, H; Xiao, BG
    Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    L.Y. Xu et al., "Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats", CLIN EXP IM, 118(1), 1999, pp. 115-121
55. Skjoldebrand-Sparre, L; Nyman, M; Broliden, K; Wahren, B
    All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    
    L. Skjoldebrand-Sparre et al., "All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid", AM J OBST G, 180(6), 1999, pp. 1595-1596
56. LI HL; SHI FD; HE B; BAKHEIT M; WAHREN B; BERGLOF A; SANDSTEDT K; LINK H
    EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS INDUCTION IN B-CELL-DEFICIENT MICE
    International immunology (Print)
    
    H.L. Li et al., "EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS INDUCTION IN B-CELL-DEFICIENT MICE", International immunology (Print), 10(9), 1998, pp. 1359-1365
57. LIU JQ; BAI XF; SHI FD; XIAO BG; LI HL; LEVI M; MUSTAFA M; WAHREN B; LINK H
    INHIBITION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN LEWIS RATSBY NASAL ADMINISTRATION OF ENCEPHALITOGENIC MBP PEPTIDES - SYNERGISTIC EFFECTS OF MBP-68-86 AND MBP-87-99
    International immunology (Print)
    
    J.Q. Liu et al., "INHIBITION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN LEWIS RATSBY NASAL ADMINISTRATION OF ENCEPHALITOGENIC MBP PEPTIDES - SYNERGISTIC EFFECTS OF MBP-68-86 AND MBP-87-99", International immunology (Print), 10(8), 1998, pp. 1139-1148
58. GHEBREKIDAN H; COX S; WAHREN B; GRANDIEN M
    PREVALENCE OF INFECTION WITH HIV, HEPATITIS-B AND HEPATITIS-C VIRUSES, IN 4 HIGH-RISK GROUPS IN ERITREA
    Clinical and diagnostic virology
    
    H. Ghebrekidan et al., "PREVALENCE OF INFECTION WITH HIV, HEPATITIS-B AND HEPATITIS-C VIRUSES, IN 4 HIGH-RISK GROUPS IN ERITREA", Clinical and diagnostic virology, 9(1), 1998, pp. 29-35
59. SAMANCI A; YI Q; FAGERBERG J; STRIGARD K; SMITH G; RUDEN U; WAHREN B; MELLSTEDT H
    PHARMACOLOGICAL ADMINISTRATION OF GRANULOCYTE MACROPHAGE-CALONY-STIMULATING FACTOR IS OF SIGNIFICANT IMPORTANCE FOR THE INDUCTION OF A STRONG HUMORAL AND CELLULAR-RESPONSE IN PATIENTS IMMUNIZED WITH RECOMBINANT CARCINOEMBRYONIC ANTIGEN/
    Cancer immunology and immunotherapy
    
    A. Samanci et al., "PHARMACOLOGICAL ADMINISTRATION OF GRANULOCYTE MACROPHAGE-CALONY-STIMULATING FACTOR IS OF SIGNIFICANT IMPORTANCE FOR THE INDUCTION OF A STRONG HUMORAL AND CELLULAR-RESPONSE IN PATIENTS IMMUNIZED WITH RECOMBINANT CARCINOEMBRYONIC ANTIGEN/", Cancer immunology and immunotherapy, 47(3), 1998, pp. 131-142
60. BRATT G; LEANDERSSON AC; ALBERT J; SANDSTROM E; WAHREN B
    MT-2 TROPISM AND CCR-5 GENOTYPE STRONGLY INFLUENCE DISEASE PROGRESSION IN HIV-1-INFECTED INDIVIDUALS
    AIDS
    
    G. Bratt et al., "MT-2 TROPISM AND CCR-5 GENOTYPE STRONGLY INFLUENCE DISEASE PROGRESSION IN HIV-1-INFECTED INDIVIDUALS", AIDS, 12(7), 1998, pp. 729-736
61. LEANDERSSON AC; BRATT G; HINKULA J; GILLJAM G; COCHAUX P; SAMSON M; SANDSTROM E; WAHREN B
    INDUCTION OF SPECIFIC T-CELL RESPONSES IN HIV-INFECTION
    AIDS
    
    A.C. Leandersson et al., "INDUCTION OF SPECIFIC T-CELL RESPONSES IN HIV-INFECTION", AIDS, 12(2), 1998, pp. 157-166
62. BRATT G; KARLSSON A; LEANDERSSON AC; ALBERT J; WAHREN B; SANDSTROM E
    TREATMENT HISTORY AND BASE-LINE VIRAL LOAD, BUT NOT VIRAL TROPISM OR CCR-5 GENOTYPE, INFLUENCE PROLONGED ANTIVIRAL EFFICACY OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT
    AIDS
    
    G. Bratt et al., "TREATMENT HISTORY AND BASE-LINE VIRAL LOAD, BUT NOT VIRAL TROPISM OR CCR-5 GENOTYPE, INFLUENCE PROLONGED ANTIVIRAL EFFICACY OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT", AIDS, 12(16), 1998, pp. 2193-2202
63. Stahle, EL; Schloss, L; Sundqvist, VA; Brytting, M; Hokeberg, I; Cox, S; Wahren, B; Linde, A
    Solid phase ELISA for determination of the virus dose dependant sensitivity of human cytomegalovirus to antiviral drugs in vitro
    ANTIVIRAL RESEARCH
    
    E.L. Stahle et al., "Solid phase ELISA for determination of the virus dose dependant sensitivity of human cytomegalovirus to antiviral drugs in vitro", ANTIVIR RES, 40(1-2), 1998, pp. 105-112
64. ZOU LP; ZHU J; DENG GM; LEVI M; WAHREN B; DIAB A; HILLERT J; LINK H
    TREATMENT WITH P2 PROTEIN PEPTIDE-57-81 BY NASAL ROUTE IS EFFECTIVE IN LEWIS RAT EXPERIMENTAL AUTOIMMUNE NEURITIS
    Journal of neuroimmunology
    
    L.P. Zou et al., "TREATMENT WITH P2 PROTEIN PEPTIDE-57-81 BY NASAL ROUTE IS EFFECTIVE IN LEWIS RAT EXPERIMENTAL AUTOIMMUNE NEURITIS", Journal of neuroimmunology, 85(2), 1998, pp. 137-145
65. DIAB A; MICHAEL L; WAHREN B; DENG GM; BJORK J; HEDLUND G; ZHU J
    LINOMIDE SUPPRESSES ACUTE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN LEWIS RATS BY COUNTER-ACTING THE IMBALANCE OF PRO-INFLAMMATORY VERSUS ANTIINFLAMMATORY CYTOKINES
    Journal of neuroimmunology
    
    A. Diab et al., "LINOMIDE SUPPRESSES ACUTE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN LEWIS RATS BY COUNTER-ACTING THE IMBALANCE OF PRO-INFLAMMATORY VERSUS ANTIINFLAMMATORY CYTOKINES", Journal of neuroimmunology, 85(2), 1998, pp. 146-154
66. ZHANG GX; SHI FD; ZHU J; XIAO BG; LEVI M; WAHREN B; YU LY; LINK H
    SYNTHETIC PEPTIDES FAIL TO INDUCE NASAL TOLERANCE TO EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS
    Journal of neuroimmunology
    
    G.X. Zhang et al., "SYNTHETIC PEPTIDES FAIL TO INDUCE NASAL TOLERANCE TO EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS", Journal of neuroimmunology, 85(1), 1998, pp. 96-101
67. CALAROTA S; BRATT G; NORDLUND S; HINKULA J; LEANDERSSON AC; SANDSTROM E; WAHREN B
    CELLULAR CYTOTOXIC RESPONSE INDUCED BY DNA VACCINATION IN HIV-1-INFECTED PATIENTS
    Lancet
    
    S. Calarota et al., "CELLULAR CYTOTOXIC RESPONSE INDUCED BY DNA VACCINATION IN HIV-1-INFECTED PATIENTS", Lancet, 351(9112), 1998, pp. 1320-1325
68. WIRGART BZ; BRYTTING M; LINDE A; WAHREN B; GRILLNER L
    SEQUENCE VARIATION WITHIN 3 IMPORTANT CYTOMEGALOVIRUS GENE REGIONS INISOLATES FROM 4 DIFFERENT PATIENT POPULATIONS
    Journal of clinical microbiology (Print)
    
    B.Z. Wirgart et al., "SEQUENCE VARIATION WITHIN 3 IMPORTANT CYTOMEGALOVIRUS GENE REGIONS INISOLATES FROM 4 DIFFERENT PATIENT POPULATIONS", Journal of clinical microbiology (Print), 36(12), 1998, pp. 3662-3669
69. PUTKONEN P; QUESADAROLANDER M; LEANDERSSON AC; SCHWARTZ S; THORSTENSSON R; OKUDA K; WAHREN B; HINKULA J
    IMMUNE-RESPONSES BUT NO PROTECTION AGAINST SHIV BY GENE-GUN DELIVERY OF HIV-1 DNA FOLLOWED BY RECOMBINANT SUBUNIT PROTEIN BOOSTS
    Virology (New York, N.Y. Print)
    
    P. Putkonen et al., "IMMUNE-RESPONSES BUT NO PROTECTION AGAINST SHIV BY GENE-GUN DELIVERY OF HIV-1 DNA FOLLOWED BY RECOMBINANT SUBUNIT PROTEIN BOOSTS", Virology (New York, N.Y. Print), 250(2), 1998, pp. 293-301
70. ZHU J; DIAB A; MUSTAFA M; LEVI M; WAHREN B; BJORK J; HEDLUND G
    LINOMIDE SUPPRESSES CHRONIC-RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN DA RATS
    Journal of the neurological sciences
    
    J. Zhu et al., "LINOMIDE SUPPRESSES CHRONIC-RELAPSING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN DA RATS", Journal of the neurological sciences, 160(2), 1998, pp. 113-120
71. ZHU J; DENG GM; LEVI M; WAHREN B; DIAB A; VANDERMEIDE PH; LINK H
    PREVENTION OF EXPERIMENTAL AUTOIMMUNE NEURITIS BY NASAL ADMINISTRATION OF P2 PROTEIN PEPTIDE-57-81
    Journal of neuropathology and experimental neurology
    
    J. Zhu et al., "PREVENTION OF EXPERIMENTAL AUTOIMMUNE NEURITIS BY NASAL ADMINISTRATION OF P2 PROTEIN PEPTIDE-57-81", Journal of neuropathology and experimental neurology, 57(3), 1998, pp. 291-301
72. LOOMISPRICE LD; COX JH; MASCOLA JR; VANCOTT TC; MICHAEL NL; FOUTS TR; REDFIELD RR; ROBB ML; WAHREN B; SHEPPARD HW; BIRX DL
    CORRELATION BETWEEN HUMORAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 ENVELOPE AND DISEASE PROGRESSION IN EARLY-STAGE INFECTION
    The Journal of infectious diseases
    
    L.D. Loomisprice et al., "CORRELATION BETWEEN HUMORAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 ENVELOPE AND DISEASE PROGRESSION IN EARLY-STAGE INFECTION", The Journal of infectious diseases, 178(5), 1998, pp. 1306-1316
73. DREXLER I; HELLER K; WAHREN B; ERFLE V; SUTTER G
    HIGHLY ATTENUATED MODIFIED VACCINIA VIRUS ANKARA REPLICATES IN BABY HAMSTER-KIDNEY CELLS, A POTENTIAL HOST FOR VIRUS PROPAGATION, BUT NOT IN VARIOUS HUMAN TRANSFORMED AND PRIMARY-CELLS
    Journal of General Virology
    
    I. Drexler et al., "HIGHLY ATTENUATED MODIFIED VACCINIA VIRUS ANKARA REPLICATES IN BABY HAMSTER-KIDNEY CELLS, A POTENTIAL HOST FOR VIRUS PROPAGATION, BUT NOT IN VARIOUS HUMAN TRANSFORMED AND PRIMARY-CELLS", Journal of General Virology, 79, 1998, pp. 347-352
74. MILLAR AL; JACKSON NAC; DALTON H; JENNINGS KR; LEVI M; WAHREN B; DIMMOCK NJ
    RAPID ANALYSIS OF EPITOPE-PARATOPE INTERACTIONS BETWEEN HIV-1 AND A 17-AMINO-ACID NEUTRALIZING MICROANTIBODY BY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY
    European journal of biochemistry
    
    A.L. Millar et al., "RAPID ANALYSIS OF EPITOPE-PARATOPE INTERACTIONS BETWEEN HIV-1 AND A 17-AMINO-ACID NEUTRALIZING MICROANTIBODY BY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY", European journal of biochemistry, 258(1), 1998, pp. 164-169
75. ISAGULIANTS MG; KADOSHNIKOV YP; KALININA TI; SMIRNOV VD; WAHREN B
    SPECIFICITY OF HUMORAL AND CELLULAR IMMUNE-RESPONSE AGAINST RECOMBINANT PARTICLES OF NUCLEOCAPSID PROTEIN OF HUMAN HEPATITIS-B VIRUS IN RABBITS
    Biochemistry
    
    M.G. Isaguliants et al., "SPECIFICITY OF HUMORAL AND CELLULAR IMMUNE-RESPONSE AGAINST RECOMBINANT PARTICLES OF NUCLEOCAPSID PROTEIN OF HUMAN HEPATITIS-B VIRUS IN RABBITS", Biochemistry, 63(5), 1998, pp. 551-558
76. WAHREN B; BRYTTING M
    DNA INCREASES THE POTENCY OF VACCINATION AGAINST INFECTIOUS-DISEASES
    CURRENT OPINION IN CHEMICAL BIOLOGY
    
    B. Wahren e M. Brytting, "DNA INCREASES THE POTENCY OF VACCINATION AGAINST INFECTIOUS-DISEASES", CURRENT OPINION IN CHEMICAL BIOLOGY, 1(2), 1997, pp. 183-189
77. LEVIN R; MHASHILKAR AM; DORFMAN T; BUKOVSKY A; ZANI G; BAGLEY J; HINKULA J; NIEDRIG M; ALBERT J; WAHREN B; GOTTLINGER HG; MARASCO WA
    INHIBITION OF EARLY AND LATE EVENTS OF THE HIV-1 REPLICATION CYCLE BYCYTOPLASMIC FAB INTRABODIES AGAINST THE MATRIX PROTEIN, P17
    Molecular medicine
    
    R. Levin et al., "INHIBITION OF EARLY AND LATE EVENTS OF THE HIV-1 REPLICATION CYCLE BYCYTOPLASMIC FAB INTRABODIES AGAINST THE MATRIX PROTEIN, P17", Molecular medicine, 3(2), 1997, pp. 96-110
78. ASAKURA Y; HINKULA J; LEANDERSSON AC; FUKUSHIMA J; OKUDA K; WAHREN B
    INDUCTION OF HIV-1 SPECIFIC MUCOSAL IMMUNE-RESPONSES BY DNA VACCINATION
    Scandinavian journal of immunology
    
    Y. Asakura et al., "INDUCTION OF HIV-1 SPECIFIC MUCOSAL IMMUNE-RESPONSES BY DNA VACCINATION", Scandinavian journal of immunology, 46(4), 1997, pp. 326-330
79. BRATT G; SANDSTROM E; ALBERT J; SAMSON M; WAHREN B
    THE INFLUENCE OF MT-2 TROPISM ON THE PROGNOSTIC IMPLICATIONS OF THE DELTA-32 DELETION IN THE CCR-5 GENE
    AIDS
    
    G. Bratt et al., "THE INFLUENCE OF MT-2 TROPISM ON THE PROGNOSTIC IMPLICATIONS OF THE DELTA-32 DELETION IN THE CCR-5 GENE", AIDS, 11(12), 1997, pp. 1415-1419
80. HINKULA J; LUNDHOLM P; WAHREN B
    NUCLEIC-ACID VACCINATION WITH HIV REGULATORY GENES - A COMBINATION OFHIV-1 GENES IN SEPARATE PLASMIDS INDUCES STRONG IMMUNE-RESPONSES
    Vaccine
    
    J. Hinkula et al., "NUCLEIC-ACID VACCINATION WITH HIV REGULATORY GENES - A COMBINATION OFHIV-1 GENES IN SEPARATE PLASMIDS INDUCES STRONG IMMUNE-RESPONSES", Vaccine, 15(8), 1997, pp. 874-878
81. KRIVORUTCHENKO YL; ANDRONOVSKAJA IB; HINKULA J; KRIVOSHEIN YS; LJUNGDAHLSTAHLE E; PERTEL SS; GRISHKOVETS VI; ZEMLYAKOV AE; WAHREN B
    STUDY OF THE ADJUVANT ACTIVITY OF NEW MDP DERIVATIVES AND PURIFIED SAPONINS AND THEIR INFLUENCE ON HIV-1 REPLICATION IN-VITRO
    Vaccine
    
    Y.L. Krivorutchenko et al., "STUDY OF THE ADJUVANT ACTIVITY OF NEW MDP DERIVATIVES AND PURIFIED SAPONINS AND THEIR INFLUENCE ON HIV-1 REPLICATION IN-VITRO", Vaccine, 15(12-13), 1997, pp. 1479-1486
82. ISAGULIANTS MG; NORDLUND S; SALLBERG M; SMIRNOV VD; RUDEN U; WAHREN B
    HIV-1 EPITOPES EXPOSED BY HYBRID HEPATITIS-B CORE PARTICLES AFFECT PROLIFERATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-1-POSITIVE DONORS (VOL 52, PG 37, 1996)
    Immunology letters
    
    M.G. Isaguliants et al., "HIV-1 EPITOPES EXPOSED BY HYBRID HEPATITIS-B CORE PARTICLES AFFECT PROLIFERATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-1-POSITIVE DONORS (VOL 52, PG 37, 1996)", Immunology letters, 55(1), 1997, pp. 61-61
83. HINKULA J; SVANHOLM C; SCHWARTZ S; LUNDHOLM P; BRYTTING M; ENGSTROM G; BENTHIN R; GLASER H; SUTTER G; KOHLEISEN B; ERFLE V; OKUDA K; WIGZELL H; WAHREN B
    RECOGNITION OF PROMINENT VIRAL EPITOPES INDUCED BY IMMUNIZATION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REGULATORY GENES
    Journal of virology
    
    J. Hinkula et al., "RECOGNITION OF PROMINENT VIRAL EPITOPES INDUCED BY IMMUNIZATION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REGULATORY GENES", Journal of virology, 71(7), 1997, pp. 5528-5539
84. OKADA E; SASAKI S; ISHII N; AOKI I; YASUDA T; NISHIOKA K; FUKUSHIMA J; MIYAZAKI J; WAHREN B; OKUDA K
    INTRANASAL IMMUNIZATION OF A DNA VACCINE WITH IL-12-COLONY-STIMULATING-FACTOR AND GRANULOCYTE-MACROPHAGE-COLONY-STIMULATING-FACTOR (GM-CSF)-EXPRESSING PLASMIDS IN LIPOSOMES INDUCES STRONG MUCOSAL AND CELL-MEDIATED IMMUNE-RESPONSES AGAINST HIV-1 ANTIGENS
    The Journal of immunology
    
    E. Okada et al., "INTRANASAL IMMUNIZATION OF A DNA VACCINE WITH IL-12-COLONY-STIMULATING-FACTOR AND GRANULOCYTE-MACROPHAGE-COLONY-STIMULATING-FACTOR (GM-CSF)-EXPRESSING PLASMIDS IN LIPOSOMES INDUCES STRONG MUCOSAL AND CELL-MEDIATED IMMUNE-RESPONSES AGAINST HIV-1 ANTIGENS", The Journal of immunology, 159(7), 1997, pp. 3638-3647
85. SASAKI S; FUKUSHIMA J; ARAI H; KUSAKABE KI; HAMAJIMA K; ISHII N; HIRAHARA F; OKUDA K; KAWAMOTO S; RUYSSCHAERT JM; VANDENBRANDEN M; WAHREN B; OKUDA K
    HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC IMMUNE-RESPONSES INDUCEDBY DNA VACCINATION ARE GREATLY ENHANCED BY MANNAN-COATED DIC14-AMIDINE
    European Journal of Immunology
    
    S. Sasaki et al., "HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC IMMUNE-RESPONSES INDUCEDBY DNA VACCINATION ARE GREATLY ENHANCED BY MANNAN-COATED DIC14-AMIDINE", European Journal of Immunology, 27(12), 1997, pp. 3121-3129
86. LOOMISPRICE LD; LEVI M; BURNETT PR; VANHAMONT JE; SHAFER RA; WAHREN B; BIRX DL
    LINEAR EPITOPE MAPPING OF HUMORAL RESPONSES INDUCED BY VACCINATION WITH RECOMBINANT HIV-1 ENVELOPE PROTEIN GP160
    Journal of industrial microbiology & biotechnology
    
    L.D. Loomisprice et al., "LINEAR EPITOPE MAPPING OF HUMORAL RESPONSES INDUCED BY VACCINATION WITH RECOMBINANT HIV-1 ENVELOPE PROTEIN GP160", Journal of industrial microbiology & biotechnology, 19(1), 1997, pp. 58-65
87. LEVI M; RUDEN U; WAHREN B
    PEPTIDE SEQUENCES OF GLYCOPROTEIN G-2 DISCRIMINATE BETWEEN HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) AND HSV-1 ANTIBODIES
    Clinical and diagnostic laboratory immunology
    
    M. Levi et al., "PEPTIDE SEQUENCES OF GLYCOPROTEIN G-2 DISCRIMINATE BETWEEN HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) AND HSV-1 ANTIBODIES", Clinical and diagnostic laboratory immunology, 3(3), 1996, pp. 265-269
88. BOTTIGER D; JOHANSSON NG; LIND P; LINDBORG B; NOREEN R; PUTKONEN P; VRANG L; WAHREN B; OBERG B
    INHIBITION OF SIV AND HIV-2 REPLICATION IN CYNOMOLGUS MONKEYS BY (-)9-[4-HYDROXY-2-(HYDROXYMETHYL)BUTYL]GUANINE (H2G)
    Antiviral chemistry & chemotherapy
    
    D. Bottiger et al., "INHIBITION OF SIV AND HIV-2 REPLICATION IN CYNOMOLGUS MONKEYS BY (-)9-[4-HYDROXY-2-(HYDROXYMETHYL)BUTYL]GUANINE (H2G)", Antiviral chemistry & chemotherapy, 7(1), 1996, pp. 21-26
89. BROLIDEN K; HINKULA J; BRATT G; PERSSON C; OTERO A; EKSTROM A; SANDSTROM E; BROLIDEN PA; WAHREN B
    ANALYSES OF FUNCTIONAL ANTIBODY-RESPONSES IN HIV-1-INFECTED INDIVIDUALS AFTER VACCINATION WITH RGP160
    Clinical and diagnostic virology
    
    K. Broliden et al., "ANALYSES OF FUNCTIONAL ANTIBODY-RESPONSES IN HIV-1-INFECTED INDIVIDUALS AFTER VACCINATION WITH RGP160", Clinical and diagnostic virology, 6(2-3), 1996, pp. 115-126
90. SHEN KL; ZHAORI G; ZWEYGBERGWIRGART B; YING M; GRANDIEN M; WAHREN B; LINDE A
    DETECTION OF RESPIRATORY VIRUSES IN NASOPHARYNGEAL SECRETIONS WITH IMMUNOFLUORESCENCE TECHNIQUE FOR MULTIPLEX SCREENING - AN EVALUATION OF THE CHEMICON ASSAY
    Clinical and diagnostic virology
    
    K.L. Shen et al., "DETECTION OF RESPIRATORY VIRUSES IN NASOPHARYNGEAL SECRETIONS WITH IMMUNOFLUORESCENCE TECHNIQUE FOR MULTIPLEX SCREENING - AN EVALUATION OF THE CHEMICON ASSAY", Clinical and diagnostic virology, 6(2-3), 1996, pp. 147-154
91. XU YH; ZHAORI G; VENE S; SHEN KL; ZHOU YT; MAGNIUS LO; WAHREN B; LINDE A
    VIRAL ETIOLOGY OF ACUTE CHILDHOOD ENCEPHALITIS IN BEIJING DIAGNOSED BY ANALYSIS OF SINGLE SAMPLES
    The Pediatric infectious disease journal
    
    Y.H. Xu et al., "VIRAL ETIOLOGY OF ACUTE CHILDHOOD ENCEPHALITIS IN BEIJING DIAGNOSED BY ANALYSIS OF SINGLE SAMPLES", The Pediatric infectious disease journal, 15(11), 1996, pp. 1018-1024
92. CALAROTA S; JANSSON M; LEVI M; BROLIDEN K; LIBONATTI O; WIGZELL H; WAHREN B
    IMMUNODOMINANT GLYCOPROTEIN-41 EPITOPE IDENTIFIED BY SEROREACTIVITY IN HIV TYPE 1-INFECTED INDIVIDUALS
    AIDS research and human retroviruses
    
    S. Calarota et al., "IMMUNODOMINANT GLYCOPROTEIN-41 EPITOPE IDENTIFIED BY SEROREACTIVITY IN HIV TYPE 1-INFECTED INDIVIDUALS", AIDS research and human retroviruses, 12(8), 1996, pp. 705-713
93. BROLIDEN K; VONGEGERFELT A; PERSSON C; HORAL P; SVENNERHOLM B; WAHREN B; BJORLING E; VAHLNE A
    IDENTIFICATION OF CROSS-REACTIVE ANTIGENIC TARGET REGIONS FOR HIV TYPE 1-SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
    AIDS research and human retroviruses
    
    K. Broliden et al., "IDENTIFICATION OF CROSS-REACTIVE ANTIGENIC TARGET REGIONS FOR HIV TYPE 1-SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY", AIDS research and human retroviruses, 12(18), 1996, pp. 1699-1702
94. PINCUS SH; WEHRLY K; COLE R; FANG H; LEWIS GK; MCCLURE J; CONLEY AJ; WAHREN B; POSNER MR; NOTKINS AL; TILLEY SA; PINTER A; EIDEN L; TEINTZE M; DORWARD D; TOLSTIKOV VV
    IN-VITRO EFFECTS OF ANTI-HIV IMMUNOTOXINS DIRECTED AGAINST MULTIPLE EPITOPES ON HIV TYPE-1 ENVELOPE GLYCOPROTEIN-160
    AIDS research and human retroviruses
    
    S.H. Pincus et al., "IN-VITRO EFFECTS OF ANTI-HIV IMMUNOTOXINS DIRECTED AGAINST MULTIPLE EPITOPES ON HIV TYPE-1 ENVELOPE GLYCOPROTEIN-160", AIDS research and human retroviruses, 12(11), 1996, pp. 1041-1051
95. CINQUE P; VAGO L; DAHL H; BRYTTING M; TERRENI MR; FORNARA C; RACCA S; CASTAGNA A; MONFORTE AD; WAHREN B; LAZZARIN A; LINDE A
    POLYMERASE CHAIN-REACTION ON CEREBROSPINAL-FLUID FOR DIAGNOSIS OF VIRUS-ASSOCIATED OPPORTUNISTIC DISEASES OF THE CENTRAL-NERVOUS-SYSTEM IN HIV-INFECTED PATIENTS
    AIDS
    
    P. Cinque et al., "POLYMERASE CHAIN-REACTION ON CEREBROSPINAL-FLUID FOR DIAGNOSIS OF VIRUS-ASSOCIATED OPPORTUNISTIC DISEASES OF THE CENTRAL-NERVOUS-SYSTEM IN HIV-INFECTED PATIENTS", AIDS, 10(9), 1996, pp. 951-958
96. GOEBEL FD; MANNHALTER JW; EIBL MM; BELSHE RB; GROB P; ERFLE V; GRIFFITHS PD; WAHREN B; KROHN K; KUNSCHAK M; ENGL W
    MULTICENTER STUDY OF SAFETY AND IMMUNOGENICITY OF HIV-1 RGP160 CANDIDATE VACCINE IN SEROPOSITIVE HIV-1 VOLUNTEERS
    AIDS
    
    F.D. Goebel et al., "MULTICENTER STUDY OF SAFETY AND IMMUNOGENICITY OF HIV-1 RGP160 CANDIDATE VACCINE IN SEROPOSITIVE HIV-1 VOLUNTEERS", AIDS, 10, 1996, pp. 64-64
97. ISAGULIANTS MG; NORDLUND S; SALLBERG M; SMIRNOV VD; RUDEN U; WAHREN B
    HIV-1 EPITOPES EXPOSED BY HYBRID HEPATITIS-B CORE PARTICLES AFFECT PROLIFERATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-1 POSITIVE DONORS
    Immunology letters
    
    M.G. Isaguliants et al., "HIV-1 EPITOPES EXPOSED BY HYBRID HEPATITIS-B CORE PARTICLES AFFECT PROLIFERATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-1 POSITIVE DONORS", Immunology letters, 52(1), 1996, pp. 37-44
98. ARMSTRONG SJ; MCINERNEY TL; MCLAIN L; WAHREN B; HINKULA J; LEVI M; DIMMOCK NJ
    2 NEUTRALIZING ANTI-V3 MONOCLONAL-ANTIBODIES ACT BY AFFECTING DIFFERENT FUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    Journal of General Virology
    
    S.J. Armstrong et al., "2 NEUTRALIZING ANTI-V3 MONOCLONAL-ANTIBODIES ACT BY AFFECTING DIFFERENT FUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1", Journal of General Virology, 77, 1996, pp. 2931-2941
99. LUNDIN K; SAMUELSSON A; JANSSON M; HINKULA J; WAHREN B; PERSSON MAA
    PEPTIDES ISOLATED FROM RANDOM PEPTIDE LIBRARIES ON PHAGE ELICIT A NEUTRALIZING ANTI-HIV-1 RESPONSE - ANALYSIS OF IMMUNOLOGICAL MIMICRY
    Immunology
    
    K. Lundin et al., "PEPTIDES ISOLATED FROM RANDOM PEPTIDE LIBRARIES ON PHAGE ELICIT A NEUTRALIZING ANTI-HIV-1 RESPONSE - ANALYSIS OF IMMUNOLOGICAL MIMICRY", Immunology, 89(4), 1996, pp. 579-586
100. ISAGULIANTS MG; KOSHIDA R; RUDEN U; WAHREN B
     LINEAR FUSION OF HIV-1 B-EPITOPES AND HETEROLOGOUS T-CELL EPITOPES .1. PRESERVATION OF THE ANTIGENIC PROPERTIES OF THE HIV-1 B-CELL EPITOPES
     Biochemistry
     
     M.G. Isaguliants et al., "LINEAR FUSION OF HIV-1 B-EPITOPES AND HETEROLOGOUS T-CELL EPITOPES .1. PRESERVATION OF THE ANTIGENIC PROPERTIES OF THE HIV-1 B-CELL EPITOPES", Biochemistry, 61(7), 1996, pp. 872-877